Enveric Biosciences Inc vs GXO Logistics Inc — how do they compare? Enveric Biosciences Inc trades at $1.59 (market cap $6.20M), while GXO Logistics Inc trades at $47.72 (market cap $5.37B). The key difference: GXO Logistics Inc is far larger — about 866.1× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | GXO | |
|---|---|---|
Market Cap | $6.20M | $5.37B |
Sector | Health | Industrials |
52-Week High | $17.40 | $65.59 |
52-Week Low | $1.27 | $45.52 |
Enterprise Value | $1.30M | $10.72B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
GXO trades at $47.64, up 1.45% today, with a bearish technical signal despite recent earnings beats. The stock shows strong analyst support with an 88.9% buy rating and a $65.67 consensus price target, implying significant upside. Recent news highlights growth in data center logistics and new partnerships, though margins remain a challenge. Cash flow improved in 2026, with net cash flow reaching $566 million.
The outlook is mixed; strong revenue growth and analyst optimism contrast with margin pressures and a bearish technical trend. Key risks include cost absorption issues and competitive threats, but the high price target suggests Wall Street sees long-term value. Investors should weigh solid fundamentals against near-term technical weakness.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →